Homeβ€ΊSearchβ€ΊHIV and AIDS Review

HIV and AIDS Review

Termedia Publishing House Ltd. Β· Poland Β· Est. 2007

ISSN1730-1270eISSN1732-2707
SJR Q3βœ“ WOS ESCIβœ“ Scopus / SJRβœ“ DOAJβœ“ Open Access
68
/ 100
Established
PubScope credibility score from verifiable indexing & ethics signals
Score Breakdown
β—† WoS ESCI56
βœ“ Corroboration (2 more)+12
Total68
Third-party records Β· how this is calculated Β· Report an error β†’
⚑ Speed vs Prestige
How does this journal balance review speed with impact level?
12
weeks to publish Β· journal-reported
Average Β· vs ~15 wk median
Q3
SJR Rank
Top 75% in field
Impact Factor & Quartile Β· Web of Science (JCR)

βœ“ Indexed in the Web of Science Core Collection (ESCI) β€” Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page β†—

The Impact Factor & JCR quartile are licensed by Clarivate β€” we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q3 Β· Scopus CiteScore 0.6. Source: Clarivate Journal Citation Reports.

SJR Scorei
0.322
H-Indexi
14
CiteScorei
0.6
SNIPi
0.186
Total Worksi
735
Total Citationsi
1,547
2yr Mean Citednessi
0.28
Open Impact Factor alternative

Aims & Scope

HIV & AIDS Review publishes several types of paper: original papers, preliminary communications, epidemiology - population studies, psychological and socio-medical aspects of HIV/AIDS, educational aspects, patient-physician relationship, conference or workshop summaries, product investigations - scientific evaluations on medical and pharmaceutical products, case reports, letters to the Editor, reviews and special reports. A limited number of articles either by invitation or following your suggestions will be of a more "tutorial" format written by experts for scientists seeking introduction into or clarification on some important issues in HIV-related research areas.

General Information

Country / RegionPoland
Primary LanguageEnglish
1st Year Published2007
FrequencyQuarterly
StatusActive (last: 2025)
Total Publications735
Publisher OrgTermedia Publishing House
OA Since2006
Visit Journal Website

Submission Info

Peer ReviewDouble-blind
Review Time~12 weeks
Acceptance Rateβ€”
OA LicenseCC BY-NC-SA
OA Rateβ€”

Ethics & Quality

COPE Memberβœ— No
OASPA Memberβœ— No
Not on Predatory Listsβœ“ Yes
Plagiarism Detectionβœ“ Yes

Think.Check.Submit Compliance

9/12 Β· 75%
βœ…
Do you know the journal / publisher?
Termedia Publishing House Ltd.
βœ…
Does the journal have a website?
βœ“ Linked
βœ…
Is the ISSN verified?
1730-1270 / 1732-2707
βœ…
Indexed in a trusted database?
WoS, Scopus, DOAJ
βœ…
Peer review process documented?
Double-blind
❌
Follows ethical publishing standards (COPE)?
N/A
❌
APC fees clearly disclosed?
N/A
βœ…
Not on predatory/blacklists?
βœ“ Clean
❌
Long-term digital preservation?
N/A
βœ…
Plagiarism detection in place?
Yes
βœ…
Listed in DOAJ (verified OA)?
DOAJ verified
βœ…
Primary language documented?
English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Citations received
45
97
2019
44
101
2020
52
90
2021
46
98
2022
48
62
2023
54
36
2024
49
4
2025
22
0
2026

Source: OpenAlex Β· Each year’s green bar = citations earned by that year’s papers, counted to date β€” so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category β€” its quartile can differ by discipline.

EpidemiologyQ3
Infectious DiseasesQ3

Subject Classification

Web of Science Categories

Infectious Diseases

Scopus Categories

Infectious DiseasesEpidemiology

Research Topics (OpenAlex)

HIV/AIDS Research and InterventionsHIV, Drug Use, Sexual RiskHIV/AIDS Impact and ResponsesHIV-related health complications and treatmentsHIV Research and TreatmentAdolescent Sexual and Reproductive HealthHIV/AIDS drug development and treatmentPneumocystis jirovecii pneumonia detection and treatmentHuman auditory perception and evaluationDiverse Scientific and Economic Studies

Frequently asked questions about HIV and AIDS Review

Is HIV and AIDS Review a predatory journal?

PubScope has no integrity flags on record for HIV and AIDS Review: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 68/100. Indexing is a transparency signal, not a guarantee β€” always confirm fit and policies before submitting.

What is the impact factor of HIV and AIDS Review?

HIV and AIDS Review is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal β€” including Arts & Humanities and Emerging Sources titles β€” receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. As an open alternative, its Scopus CiteScore is 0.6.

Is HIV and AIDS Review indexed in Scopus and Web of Science?

HIV and AIDS Review is indexed in Web of Science, Scopus, DOAJ.

What is the aims and scope of HIV and AIDS Review?

HIV & AIDS Review publishes several types of paper: original papers, preliminary communications, epidemiology - population studies, psychological and socio-medical aspects of HIV/AIDS, educational aspects, patient-physician relationship, conference or workshop summaries, product investigations - scientific evaluations on medical and pharmaceutical products, case reports, letters to the Editor, reviews and special reports. A limited number of articles either by invitation or following your suggestions will be of a more "tutorial" format written by experts for scientists seeking introduction int

Compare This JournalFind Similar← Back to Search
Understand these signals
How to tell if a journal is predatoryWhat Q1–Q4 quartiles meanWeb of Science vs Scopus vs DOAJWhat is an APC?

Data updated: 2026-05-22 Β· Sources: SJR, DOAJ, OpenAlex, WoS, Crossref